Madrigal Pharmaceuticals Inc (MDGL) — Cash Flow-to-Debt Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Cash Flow-to-Debt Ratio of -0.20x as of December 2025, meaning its operating cash flow of $-133.46 Million could theoretically repay 0% of its total liabilities ($656.90 Million) in one year. See Madrigal Pharmaceuticals Inc (MDGL) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Madrigal Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Madrigal Pharmaceuticals Inc across 23 annual periods. For the full cash flow conversion analysis, see Madrigal Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Madrigal Pharmaceuticals Inc (2003–2025)
Year-by-year debt coverage analysis for Madrigal Pharmaceuticals Inc. Check Madrigal Pharmaceuticals Inc (MDGL) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.29x | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-455.57 Million | $287.86 Million | ▼ -14.8% |
| 2023 | -1.38x | $-324.23 Million | $235.21 Million | ▼ -1.3% |
| 2022 | -1.36x | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.35x | $-157.56 Million | $47.02 Million | ▼ -105.2% |
| 2019 | -1.63x | $-41.62 Million | $25.49 Million | ▲ +45.9% |
| 2018 | -3.02x | $-25.51 Million | $8.44 Million | ▼ -36.1% |
| 2017 | -2.22x | $-22.32 Million | $10.05 Million | ▲ +39.5% |
| 2016 | -3.67x | $-17.61 Million | $4.80 Million | ▲ +8.7% |
| 2015 | -4.02x | $-71.44 Million | $17.79 Million | ▼ -80.9% |
| 2014 | -2.22x | $-78.92 Million | $35.54 Million | ▼ -32.3% |
| 2013 | -1.68x | $-77.41 Million | $46.11 Million | ▲ +13.3% |
| 2012 | -1.94x | $-54.13 Million | $27.95 Million | ▼ -12.8% |
| 2011 | -1.72x | $-47.30 Million | $27.55 Million | ▼ -37.5% |
| 2010 | -1.25x | $-38.20 Million | $30.59 Million | ▼ -11.8% |
| 2009 | -1.12x | $-26.81 Million | $24.00 Million | ▼ -359.5% |
| 2008 | -0.24x | $-37.94 Million | $156.04 Million | ▼ -187.3% |
| 2007 | 0.28x | $27.22 Million | $97.75 Million | ▲ +129.7% |
| 2006 | -0.94x | $-52.98 Million | $56.54 Million | ▲ +71.6% |
| 2005 | -3.30x | $-61.88 Million | $18.73 Million | ▼ -37.5% |
| 2004 | -2.40x | $-33.80 Million | $14.06 Million | ▲ +64.4% |
| 2003 | -6.75x | $-23.61 Million | $3.50 Million | — |